|
||
Calcitine Pregnancy |
||
Maternal Calcitine may be detected in the fetal circulation. Mild hypercalcemia has been reported in a newborn following maternal use of Calcitine during pregnancy. Adverse effects on fetal development were not observed with use of Calcitine during pregnancy in women (N=9) with pseudovitamin D-dependent rickets. Doses were adjusted every 4 weeks to keep calcium concentrations within normal limits (Edouard 2011). If Calcitine is used for the management of hypoparathyroidism in pregnancy, dose adjustments may be needed as pregnancy progresses and again following delivery. Vitamin D and calcium levels should be monitored closely and kept in the lower normal range (Callies 1998).
Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: -It is presumed that this drug passes into breast milk. -If used during breastfeeding, monitor the serum calcium levels of the mother and the infant.
See references
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|